X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with Cipla - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs CIPLA - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

CIPLA 
   Change

Cipla is one of the largest pharma companies in the domestic market and has presence in formulations and bulk drugs manufacturing. All the bulk drug manufacturing facilities of the company have been approved by various authorities including the US FD... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD CIPLA MERCK LTD/
CIPLA
 
P/E (TTM) x 33.8 45.0 75.0% View Chart
P/BV x 3.8 3.9 98.0% View Chart
Dividend Yield % 0.7 0.3 224.9%  

Financials

 MERCK LTD   CIPLA
EQUITY SHARE DATA
    MERCK LTD
Dec-16
CIPLA
Mar-17
MERCK LTD/
CIPLA
5-Yr Chart
Click to enlarge
High Rs1,060622 170.4%   
Low Rs623458 135.9%   
Sales per share (Unadj.) Rs632.4181.9 347.8%  
Earnings per share (Unadj.) Rs45.712.9 355.2%  
Cash flow per share (Unadj.) Rs62.329.3 212.6%  
Dividends per share (Unadj.) Rs11.002.00 550.0%  
Dividend yield (eoy) %1.30.4 353.0%  
Book value per share (Unadj.) Rs388.8155.7 249.7%  
Shares outstanding (eoy) m16.60804.51 2.1%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x1.33.0 44.8%   
Avg P/E ratio x18.442.0 43.9%  
P/CF ratio (eoy) x13.518.4 73.3%  
Price / Book Value ratio x2.23.5 62.4%  
Dividend payout %24.115.5 154.8%   
Avg Mkt Cap Rs m13,969434,516 3.2%   
No. of employees `0001.623.0 6.9%   
Total wages/salary Rs m1,48726,338 5.6%   
Avg. sales/employee Rs Th6,631.96,349.1 104.5%   
Avg. wages/employee Rs Th939.21,143.0 82.2%   
Avg. net profit/employee Rs Th479.4449.3 106.7%   
INCOME DATA
Net Sales Rs m10,498146,302 7.2%  
Other income Rs m2422,287 10.6%   
Total revenues Rs m10,741148,589 7.2%   
Gross profit Rs m1,13524,758 4.6%  
Depreciation Rs m27613,229 2.1%   
Interest Rs m01,594 0.0%   
Profit before tax Rs m1,10212,222 9.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-70 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3431,798 19.1%   
Profit after tax Rs m75910,354 7.3%  
Gross profit margin %10.816.9 63.9%  
Effective tax rate %31.114.7 211.8%   
Net profit margin %7.27.1 102.1%  
BALANCE SHEET DATA
Current assets Rs m6,41087,370 7.3%   
Current liabilities Rs m8,82833,081 26.7%   
Net working cap to sales %-23.037.1 -62.1%  
Current ratio x0.72.6 27.5%  
Inventory Days Days5887 66.3%  
Debtors Days Days3862 61.6%  
Net fixed assets Rs m1,406111,567 1.3%   
Share capital Rs m1661,609 10.3%   
"Free" reserves Rs m6,286123,645 5.1%   
Net worth Rs m6,455125,254 5.2%   
Long term debt Rs m036,454 0.0%   
Total assets Rs m8,828209,532 4.2%  
Interest coverage xNM8.7-  
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x1.20.7 170.3%   
Return on assets %8.65.7 150.8%  
Return on equity %11.88.3 142.2%  
Return on capital %17.18.5 200.9%  
Exports to sales %8.334.2 24.2%   
Imports to sales %21.08.3 252.3%   
Exports (fob) Rs m86950,050 1.7%   
Imports (cif) Rs m2,20912,203 18.1%   
Fx inflow Rs m95951,066 1.9%   
Fx outflow Rs m2,61217,678 14.8%   
Net fx Rs m-1,65333,388 -5.0%   
CASH FLOW
From Operations Rs m1,07023,824 4.5%  
From Investments Rs m-750-13,127 5.7%  
From Financial Activity Rs m-150-13,239 1.1%  
Net Cashflow Rs m171-2,478 -6.9%  

Share Holding

Indian Promoters % 0.0 16.0 -  
Foreign collaborators % 51.8 20.8 249.0%  
Indian inst/Mut Fund % 18.2 12.2 149.2%  
FIIs % 1.0 23.7 4.2%  
ADR/GDR % 0.0 1.1 -  
Free float % 29.1 26.2 111.1%  
Shareholders   28,591 161,166 17.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   ASTRAZENECA PHARMA  ALEMBIC PHARMA  ELDER PHARMA  NOVARTIS  DR. DATSONS LABS  

Compare MERCK LTD With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes Marginally Lower; Capital Goods & Realty Stocks Fall(Closing)

Indian share markets witnessed selling pressure in the final hour of trade to finish just below the dotted line. At the closing bell, the BSE Sensex closed lower by 71 points.

Related Views on News

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Cipla: Extraordinary Income Boosts Net Profits (Quarterly Results Update - Detailed)

Oct 30, 2017

Proceeds from the sale of the South African animal business bolstered Cipla's net profits for the quarter.

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Feb 20, 2018 03:35 PM

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MERCK LTD 8-QTR ANALYSIS

COMPARE MERCK LTD WITH

MARKET STATS